PMID- 18364397 OWN - NLM STAT- MEDLINE DCOM- 20080812 LR - 20211020 IS - 1530-6860 (Electronic) IS - 0892-6638 (Print) IS - 0892-6638 (Linking) VI - 22 IP - 7 DP - 2008 Jul TI - Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice. PG - 2569-78 LID - 10.1096/fj.07-105353 [doi] AB - A causal relationship between diet-induced hyperhomocysteinemia (HHcy) and accelerated atherosclerosis has been established in apolipoprotein E-deficient (apoE(-/-)) mice. However, it is not known whether the proatherogenic effect of HHcy in apoE(-/-) mice is independent of hyperlipidemia and/or deficiency of apoE. In this study, a comprehensive dietary approach using C57BL/6J mice was used to investigate whether HHcy is an independent risk factor for accelerated atherosclerosis or dependent on additional dietary factors that increase plasma lipids and/or inflammation. C57BL/6J mice at 4 wk of age were divided into 6 dietary groups: chow diet (C), chow diet + methionine (C+M), western-type diet (W), western-type diet + methionine (W+M), atherogenic diet (A), or atherogenic diet + methionine (A+M). After 2, 10, 20, or 40 wk on the diets, mice were sacrificed, and the levels of total plasma homocysteine, cysteine, and glutathione, as well as total plasma cholesterol and triglycerides were analyzed. Aortic root sections were examined for atherosclerotic lesions. HHcy was induced in all groups supplemented with methionine, compared to diet-matched control groups. Plasma total cholesterol was significantly increased in mice fed the W or A diet. However, the W diet increased LDL/IDL and HDL levels, while the A diet significantly elevated plasma VLDL and LDL/IDL levels without increasing HDL. No differences in plasma total cholesterol levels or lipid profiles were observed between methionine-supplemented groups and the diet-matched control groups. Early atherosclerotic lesions containing macrophage foam cells were only observed in mice fed the A or A + M diet. Furthermore, lesion size was significantly larger in the A + M group compared to the A group at 10 and 20 wk; however, mature lesions were never observed even after 40 wk on these diets. The presence of lymphocytes, increased hyaluronan staining, and the expression of endoplasmic reticulum (ER) stress markers were also increased in atherosclerotic lesions from the A + M group. Taken together, these results suggest that HHcy does not independently cause atherosclerosis in C57BL/6J mice even in the presence of increased total plasma lipids induced by the W diet. However, HHcy can accelerate atherosclerotic lesion development under dietary conditions that increase plasma VLDL levels and/or inflammation. FAU - Zhou, Ji AU - Zhou J AD - Department of Medicine, McMaster University, Hamilton, Ontario, Canada. FAU - Werstuck, Geoff H AU - Werstuck GH FAU - Lhotak, Sarka AU - Lhotak S FAU - Shi, Yuan Y AU - Shi YY FAU - Tedesco, Vivienne AU - Tedesco V FAU - Trigatti, Bernardo AU - Trigatti B FAU - Dickhout, Jeffrey AU - Dickhout J FAU - Majors, Alana K AU - Majors AK FAU - DiBello, Patricia M AU - DiBello PM FAU - Jacobsen, Donald W AU - Jacobsen DW FAU - Austin, Richard C AU - Austin RC LA - eng GR - R01 HL052234/HL/NHLBI NIH HHS/United States GR - R37 HL052234/HL/NHLBI NIH HHS/United States GR - R37 HL052234-14/HL/NHLBI NIH HHS/United States GR - HL52234/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20080325 PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Lipids) RN - 0LVT1QZ0BA (Homocysteine) RN - 9004-61-9 (Hyaluronic Acid) RN - AE28F7PNPL (Methionine) SB - IM MH - Animals MH - Atherosclerosis/blood/chemically induced/pathology/*physiopathology MH - Diet, Atherogenic MH - Dietary Supplements MH - Disease Models, Animal MH - Female MH - Homocysteine/blood MH - Hyaluronic Acid/metabolism MH - Hyperhomocysteinemia/blood/*chemically induced/pathology/*physiopathology MH - Immunohistochemistry MH - Lipids/blood MH - Methionine/administration & dosage/*pharmacology MH - Mice MH - Mice, Inbred C57BL PMC - PMC2846632 MID - NIHMS184691 EDAT- 2008/03/28 09:00 MHDA- 2008/08/13 09:00 PMCR- 2010/03/29 CRDT- 2008/03/28 09:00 PHST- 2008/03/28 09:00 [pubmed] PHST- 2008/08/13 09:00 [medline] PHST- 2008/03/28 09:00 [entrez] PHST- 2010/03/29 00:00 [pmc-release] AID - fj.07-105353 [pii] AID - 10.1096/fj.07-105353 [doi] PST - ppublish SO - FASEB J. 2008 Jul;22(7):2569-78. doi: 10.1096/fj.07-105353. Epub 2008 Mar 25.